scholarly journals Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence

Medicine ◽  
2020 ◽  
Vol 99 (6) ◽  
pp. e18948 ◽  
Author(s):  
Antonio Riccardo Buonomo ◽  
Riccardo Scotto ◽  
Carmine Coppola ◽  
Biagio Pinchera ◽  
Giulio Viceconte ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
De Novo ◽  
Hepatitis C Virus Infection ◽  
Direct Acting Antivirals ◽  
Direct Acting ◽  
De Novo Hepatocellular Carcinoma

A genetic risk score predicts de novo hepatocellular carcinoma in hepatitis C cirrotic patients treated with direct-acting antivirals

2020 ◽  
Vol 73 ◽  
pp. S208-S209
Author(s):  
Elisabetta Degasperi ◽  
Enrico Galmozzi ◽  
Serena Pelusi ◽  
Roberta D’ambrosio ◽  
Roberta Soffredini ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis C ◽  
Risk Score ◽  
Genetic Risk ◽  
De Novo ◽  
Genetic Risk Score ◽  
Direct Acting Antivirals ◽  
Direct Acting ◽  
De Novo Hepatocellular Carcinoma

scholarly journals Provider verification of electronic health record receipt and nonreceipt of direct-acting antivirals for the treatment of hepatitis C virus infection

2018 ◽  
Vol 28 (11) ◽  
pp. 808-811
Author(s):  
Christopher T. Rentsch ◽  
Emily J. Cartwright ◽  
Neel R. Gandhi ◽  
Sheldon T. Brown ◽  
Maria C. Rodriguez-Barradas ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Electronic Health Record ◽  
Health Record ◽  
Hepatitis C Virus Infection ◽  
Direct Acting Antivirals ◽  
Electronic Health ◽  
Direct Acting
Sign in / Sign up

Export Citation Format

Share Document